{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:00:57Z","timestamp":1785211257861,"version":"3.55.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1053\/j.seminhematol.2026.06.002","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:12:11Z","timestamp":1780675931000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Alloimmunization in sickle cell disease: Addressing an ongoing clinical challenge"],"prefix":"10.1053","author":[{"given":"Alistair","family":"Murray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean R.","family":"Stowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1053\/j.seminhematol.2026.06.002_bib0001","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1016\/S2352-3026(23)00066-2","article-title":"Alloimmunisation against red blood cells in sickle cell disease: transfusion challenges in high-income and low-income countries","volume":"10","author":"Pirenne","year":"2023","journal-title":"Lancet Haematol."},{"issue":"1","key":"10.1053\/j.seminhematol.2026.06.002_bib0002","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1182\/asheducation-2016.1.457","article-title":"Immunoregulatory networks in sickle cell alloimmunization","volume":"2016","author":"Yazdanbakhsh","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program."},{"issue":"1","key":"10.1053\/j.seminhematol.2026.06.002_bib0003","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1182\/asheducation-2016.1.452","article-title":"Cellular immune responses in red blood cell alloimmunization","volume":"2016","author":"Zimring","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program."},{"key":"10.1053\/j.seminhematol.2026.06.002_bib0004","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev-pathol-042320-110411","article-title":"The Development and Consequences of Red Blood Cell Alloimmunization","volume":"18","author":"Arthur","year":"2023","journal-title":"Annu Rev Pathol."},{"issue":"8","key":"10.1053\/j.seminhematol.2026.06.002_bib0005","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/trf.16967","article-title":"Unmasking delayed hemolytic transfusion reactions in patients with sickle-cell disease: Challenges and opportunities for improvement","volume":"62","author":"Covington","year":"2022","journal-title":"Transfusion (Paris)"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.06.002_bib0006","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/bjh.15182","article-title":"Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database","volume":"181","author":"Karafin","year":"2018","journal-title":"Br J Haematol."},{"issue":"7","key":"10.1053\/j.seminhematol.2026.06.002_bib0007","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3324\/haematol.2020.270546","article-title":"Red cell transfusion and alloimmunization in sickle cell disease","volume":"106","author":"Linder","year":"2021","journal-title":"Haematologica."},{"issue":"9","key":"10.1053\/j.seminhematol.2026.06.002_bib0008","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3324\/haematol.2016.147181","article-title":"Altered heme-mediated modulation of dendritic cell function in sickle cell alloimmunization","volume":"101","author":"Godefroy","year":"2016","journal-title":"Haematologica"},{"issue":"11","key":"10.1053\/j.seminhematol.2026.06.002_bib0009","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3324\/haematol.2015.132738","article-title":"TIGIT-positive circulating follicular helper T cells display robust B-cell help functions: potential role in sickle cell alloimmunization","volume":"100","author":"Godefroy","year":"2015","journal-title":"Haematologica."},{"issue":"1","key":"10.1053\/j.seminhematol.2026.06.002_bib0010","first-page":"102","article-title":"Hemin controls T cell polarization in sickle cell alloimmunization","volume":"193","author":"Zhong","year":"2014","journal-title":"J Immunol Baltim Md 1950."},{"issue":"3","key":"10.1053\/j.seminhematol.2026.06.002_bib0011","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/trf.17251","article-title":"Storage differentially impacts alloimmunization to distinct red cell antigens following transfusion in mice","volume":"63","author":"Maier","year":"2023","journal-title":"Transfusion (Paris)."},{"issue":"5","key":"10.1053\/j.seminhematol.2026.06.002_bib0012","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1537-2995.1988.28588337338.x","article-title":"Red cell alloimmunization in multitransfused HLA-typed patients","volume":"28","author":"Brantley","year":"1988","journal-title":"Transfusion (Paris)."},{"issue":"6","key":"10.1053\/j.seminhematol.2026.06.002_bib0013","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/bjh.15998","article-title":"Identification of genetic biomarkers for alloimmunization in sickle cell disease","volume":"186","author":"Meinderts","year":"2019","journal-title":"Br J Haematol."},{"issue":"19","key":"10.1053\/j.seminhematol.2026.06.002_bib0014","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1182\/blood-2017-05-784876","article-title":"Nonclassical FCGR2C haplotype is associated with protection from red blood cell alloimmunization in sickle cell disease","volume":"130","author":"Meinderts","year":"2017","journal-title":"Blood."},{"issue":"2","key":"10.1053\/j.seminhematol.2026.06.002_bib0015","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/trf.13920","article-title":"Red blood cell alloimmunization in patients with sickle cell disease: correlation with HLA and cytokine gene polymorphisms","volume":"57","author":"Sippert","year":"2017","journal-title":"Transfusion (Paris)"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.06.002_bib0016","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1182\/blood.2024026109","article-title":"Ferroptosis regulates hemolysis in stored murine and human red blood cells","volume":"145","author":"D\u2019Alessandro","year":"2025","journal-title":"Blood"},{"issue":"15","key":"10.1053\/j.seminhematol.2026.06.002_bib0017","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1182\/bloodadvances.2019000605","article-title":"Differences in Steap3 expression are a mechanism of genetic variation of RBC storage and oxidative damage in mice","volume":"3","author":"Howie","year":"2019","journal-title":"Blood Adv."},{"issue":"3","key":"10.1053\/j.seminhematol.2026.06.002_bib0018","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2011-11-327361","article-title":"Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management","volume":"120","author":"Yazdanbakhsh","year":"2012","journal-title":"Blood."},{"key":"10.1053\/j.seminhematol.2026.06.002_bib0019","doi-asserted-by":"crossref","first-page":"q2147","DOI":"10.1136\/bmj.q2147","article-title":"Sickle cell drug is withdrawn over safety concerns just months after rollout","author":"Mahase","year":"2024","journal-title":"BMJ."},{"issue":"10019","key":"10.1053\/j.seminhematol.2026.06.002_bib0020","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(15)01041-7","article-title":"Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial","volume":"387","author":"Ware","year":"2016","journal-title":"Lancet."},{"issue":"17","key":"10.1053\/j.seminhematol.2026.06.002_bib0021","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2011-11-392340","article-title":"Stroke With Transfusions Changing to Hydroxyurea (SWiTCH)","volume":"119","author":"Ware","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.06.002_bib0022","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajh.25308","article-title":"Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysis","volume":"94","author":"Kutlar","year":"2019","journal-title":"Am J Hematol."},{"issue":"3","key":"10.1053\/j.seminhematol.2026.06.002_bib0023","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1715971","article-title":"A Phase 3 Trial of l-Glutamine in Sickle Cell Disease","volume":"379","author":"Niihara","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1053\/j.seminhematol.2026.06.002_bib0024","doi-asserted-by":"crossref","DOI":"10.1177\/20503121231224551","article-title":"Cost-effectiveness of l-glutamine versus crizanlizumab for adults with sickle cell disease: model focused on reducing pain episode costs from Qatar\u2019s healthcare perspective","volume":"12","author":"Adel","year":"2024","journal-title":"SAGE Open Med."},{"issue":"6","key":"10.1053\/j.seminhematol.2026.06.002_bib0025","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/MOH.0000000000000282","article-title":"Allogeneic stem cell transplantation for sickle cell disease","volume":"23","author":"Robinson","year":"2016","journal-title":"Curr Opin Hematol."},{"issue":"11","key":"10.1053\/j.seminhematol.2026.06.002_bib0026","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2016-10-745711","article-title":"Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation","volume":"129","author":"Gluckman","year":"2017","journal-title":"Blood."},{"issue":"7","key":"10.1053\/j.seminhematol.2026.06.002_bib0027","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2117175","article-title":"Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease","volume":"386","author":"Kanter","year":"2022","journal-title":"N Engl J Med."},{"issue":"10419","key":"10.1053\/j.seminhematol.2026.06.002_bib0028","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/S0140-6736(23)02797-6","article-title":"The promise of genetic therapies in sickle cell disease","volume":"402","year":"2023","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.06.002_bib0029","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1537-2995.2009.02435.x","article-title":"Red blood cell alloimmunization in sickle cell disease patients in Uganda","volume":"50","author":"Natukunda","year":"2010","journal-title":"Transfusion (Paris)"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.06.002_bib0030","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1365-2141.2001.02819.x","article-title":"Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom","volume":"113","author":"Olujohungbe","year":"2001","journal-title":"Br J Haematol."},{"issue":"6 Suppl 4","key":"10.1053\/j.seminhematol.2026.06.002_bib0031","doi-asserted-by":"crossref","first-page":"S398","DOI":"10.1016\/j.amepre.2011.09.013","article-title":"Sickle cell disease in Africa: a neglected cause of early childhood mortality","volume":"41","author":"Grosse","year":"2011","journal-title":"Am J Prev Med."},{"issue":"2","key":"10.1053\/j.seminhematol.2026.06.002_bib0032","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/bjh.13123","article-title":"Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease","volume":"168","author":"Fasano","year":"2015","journal-title":"Br J Haematol."},{"issue":"1","key":"10.1053\/j.seminhematol.2026.06.002_bib0033","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0609.1998.tb01060.x","article-title":"Acute phase proteins and interleukins in steady state sickle cell disease","volume":"61","author":"Bourantas","year":"1998","journal-title":"Eur J Haematol."},{"issue":"1","key":"10.1053\/j.seminhematol.2026.06.002_bib0034","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/153537020523000109","article-title":"Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease","volume":"230","author":"Hibbert","year":"2005","journal-title":"Exp Biol Med Maywood NJ."},{"issue":"9","key":"10.1053\/j.seminhematol.2026.06.002_bib0035","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/j.1537-2995.2006.00946.x","article-title":"Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells","volume":"46","author":"Hendrickson","year":"2006","journal-title":"Transfusion (Paris)."},{"issue":"9","key":"10.1053\/j.seminhematol.2026.06.002_bib0036","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1111\/j.1537-2995.2008.01801.x","article-title":"Discrete Toll-like receptor agonists have differential effects on alloimmunization to transfused red blood cells","volume":"48","author":"Hendrickson","year":"2008","journal-title":"Transfusion (Paris)."},{"issue":"17","key":"10.1053\/j.seminhematol.2026.06.002_bib0037","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1182\/bloodadvances.2022008647","article-title":"Proinflammatory state promotes red blood cell alloimmunization in pediatric patients with sickle cell disease","volume":"7","author":"Zheng","year":"2023","journal-title":"Blood Adv."},{"issue":"6 Pt 2","key":"10.1053\/j.seminhematol.2026.06.002_bib0038","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/trf.12940","article-title":"Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival","volume":"55","author":"Telen","year":"2015","journal-title":"Transfusion (Paris)"},{"issue":"20","key":"10.1053\/j.seminhematol.2026.06.002_bib0039","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1182\/bloodadvances.2022006982","article-title":"Red cell alloimmunization is associated with increased health care costs, longer hospitalizations, and higher mortality","volume":"6","author":"Viayna","year":"2022","journal-title":"Blood Adv."},{"issue":"3","key":"10.1053\/j.seminhematol.2026.06.002_bib0040","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3324\/haematol.2019.224709","article-title":"Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal","volume":"105","author":"Thein","year":"2020","journal-title":"Haematologica."},{"issue":"1","key":"10.1053\/j.seminhematol.2026.06.002_bib0041","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/trf.13379","article-title":"Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series","volume":"56","author":"Nickel","year":"2016","journal-title":"Transfusion (Paris)."},{"issue":"5","key":"10.1053\/j.seminhematol.2026.06.002_bib0042","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/bjh.13339","article-title":"Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience","volume":"169","author":"Vidler","year":"2015","journal-title":"Br J Haematol."},{"issue":"Supplement 1","key":"10.1053\/j.seminhematol.2026.06.002_bib0043","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1182\/blood-2021-149761","article-title":"Causes and Circumstances of Death: Analysis in 266 Sickle Cell Adult Patients","volume":"138","author":"Habibi","year":"2021","journal-title":"Blood."},{"issue":"10","key":"10.1053\/j.seminhematol.2026.06.002_bib0044","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/ajh.24460","article-title":"Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes","volume":"91","author":"Habibi","year":"2016","journal-title":"Am J Hematol."},{"issue":"12","key":"10.1053\/j.seminhematol.2026.06.002_bib0045","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/ajh.24908","article-title":"Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease","volume":"92","author":"Narbey","year":"2017","journal-title":"Am J Hematol."},{"issue":"1","key":"10.1053\/j.seminhematol.2026.06.002_bib0046","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1182\/hematology.2023000499","article-title":"Alloimmunization and hyperhemolysis in sickle cell disease","volume":"2023","author":"Pirenne","year":"2023","journal-title":"Hematol Am Soc Hematol Educ Program."},{"issue":"2","key":"10.1053\/j.seminhematol.2026.06.002_bib0047","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.tracli.2019.02.008","article-title":"Complement activation during intravascular hemolysis: Implication for sickle cell disease and hemolytic transfusion reactions","volume":"26","author":"Merle","year":"2019","journal-title":"Transfus Clin Biol J Soc Francaise Transfus Sang."},{"issue":"4","key":"10.1053\/j.seminhematol.2026.06.002_bib0048","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tmrv.2019.09.007","article-title":"The role of Complement in Post-Transfusion Hemolysis and Hyperhemolysis Reaction","volume":"33","author":"Roumenina","year":"2019","journal-title":"Transfus Med Rev."},{"key":"10.1053\/j.seminhematol.2026.06.002_bib0049","unstructured":"Serious Hazards of Transfusion [Internet]. [cited 2025 Jan 6]. 2023 Annual SHOT Report \u2013 Individual Chapters. Available from: https:\/\/www.shotuk.org\/shot-reports\/report-summary-and-supplement-2023\/2023-annual-shot-report-individual-chapters\/"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.06.002_bib0050","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/vox.12234","article-title":"Passive reporting greatly underestimates the rate of transfusion-associated circulatory overload after platelet transfusion","volume":"108","author":"Raval","year":"2015","journal-title":"Vox Sang."},{"issue":"4","key":"10.1053\/j.seminhematol.2026.06.002_bib0051","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.htct.2019.09.006","article-title":"Determining the true incidence of acute transfusion reactions: Active surveillance at a specialized liver center","volume":"42","author":"Sahu","year":"2020","journal-title":"Hematol Transfus Cell Ther."},{"issue":"10","key":"10.1053\/j.seminhematol.2026.06.002_bib0052","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1111\/trf.13730","article-title":"Incidence of transfusion reactions: a multicenter study utilizing systematic active surveillance and expert adjudication","volume":"56","author":"Hendrickson","year":"2016","journal-title":"Transfusion (Paris)."},{"issue":"3","key":"10.1053\/j.seminhematol.2026.06.002_bib0053","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3324\/haematol.2019.224709","article-title":"Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal","volume":"105","author":"Thein","year":"2020","journal-title":"Haematologica."},{"issue":"2","key":"10.1053\/j.seminhematol.2026.06.002_bib0054","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/trf.15010","article-title":"Multiple hemolytic transfusion reactions misinterpreted as severe vaso-occlusive crisis in a patient with sickle cell disease","volume":"59","author":"Dean","year":"2019","journal-title":"Transfusion (Paris)."},{"issue":"2","key":"10.1053\/j.seminhematol.2026.06.002_bib0055","doi-asserted-by":"crossref","first-page":"231","DOI":"10.7326\/0003-4819-93-2-231","article-title":"Delayed hemolytic transfusion reaction presenting as sickle-cell crisis","volume":"93","author":"Diamond","year":"1980","journal-title":"Ann Intern Med."},{"key":"10.1053\/j.seminhematol.2026.06.002_bib0056","unstructured":"US Centers for Disease Control and Prevention. National Healthcare Safety Network Biovigilance Component Hemovigilance Module Surveillance Protocol v2.9 2025. [cited 30 March 35]. Available from www.cdc.gov\/nhsn\/PDFs\/Biovigilance\/BV-HV-protocol-current.pdf."},{"issue":"23","key":"10.1053\/j.seminhematol.2026.06.002_bib0057","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1182\/bloodadvances.2019000916","article-title":"American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease","volume":"3","author":"Liem","year":"2019","journal-title":"Blood Adv."},{"issue":"9870","key":"10.1053\/j.seminhematol.2026.06.002_bib0058","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0140-6736(12)61726-7","article-title":"The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial","volume":"381","author":"Howard","year":"2013","journal-title":"Lancet Lond Engl."},{"issue":"2","key":"10.1053\/j.seminhematol.2026.06.002_bib0059","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/bloodadvances.2019001143","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support","volume":"4","author":"Chou","year":"2020","journal-title":"Blood Adv."},{"issue":"8","key":"10.1053\/j.seminhematol.2026.06.002_bib0060","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1399-3046.2006.00608.x","article-title":"Plasma cell-rich acute cellular rejection of a transplanted kidney associated with antibody to the red cell Kidd antigen","volume":"10","author":"Hamilton","year":"2006","journal-title":"Pediatr Transplant."},{"issue":"1","key":"10.1053\/j.seminhematol.2026.06.002_bib0061","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1537-2995.2007.01060.x","article-title":"Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection?","volume":"47","author":"Lerut","year":"2007","journal-title":"Transfusion (Paris)."},{"issue":"3","key":"10.1053\/j.seminhematol.2026.06.002_bib0062","doi-asserted-by":"crossref","first-page":"90","DOI":"10.21307\/immunohematology-2019-156","article-title":"Implications of the Kidd blood group system in renal transplantation","volume":"28","author":"Rourk","year":"2012","journal-title":"Immunohematology."},{"key":"10.1053\/j.seminhematol.2026.06.002_bib0063","first-page":"124","article-title":"Consequences of frequent hemodialysis: comparison to conventional hemodialysis and transplantation","volume":"122","author":"Stokes","year":"2011","journal-title":"Trans Am Clin Climatol Assoc."},{"issue":"4","key":"10.1053\/j.seminhematol.2026.06.002_bib0064","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/bjh.18311","article-title":"Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor-mobilized patients with sickle cell disease","volume":"198","author":"Sharma","year":"2022","journal-title":"Br J Haematol."},{"issue":"9","key":"10.1053\/j.seminhematol.2026.06.002_bib0065","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1182\/blood.2023020728","article-title":"How I treat sickle cell disease in pregnancy","volume":"143","author":"James","year":"2024","journal-title":"Blood"},{"issue":"Supplement 1","key":"10.1053\/j.seminhematol.2026.06.002_bib0066","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/blood-2023-178410","article-title":"Comparison of Alloimmunization in Pregnant People with Sickle Cell Disease Receiving Chronic Versus on-Demand Transfusions: A Multinational Study","volume":"142","author":"Zarka","year":"2023","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.06.002_bib0067","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3324\/haematol.10937","article-title":"Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London","volume":"92","author":"Telfer","year":"2007","journal-title":"Haematologica."},{"issue":"17","key":"10.1053\/j.seminhematol.2026.06.002_bib0068","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1182\/blood-2009-07-233700","article-title":"Improved survival of children and adolescents with sickle cell disease","volume":"115","author":"Quinn","year":"2010","journal-title":"Blood."},{"issue":"11","key":"10.1053\/j.seminhematol.2026.06.002_bib0069","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1182\/blood-2009-04-214387","article-title":"Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model","volume":"114","author":"Desmarets","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.06.002_bib0070","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1182\/blood-2011-09-382655","article-title":"Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs","volume":"119","author":"Smith","year":"2012","journal-title":"Blood."},{"issue":"8","key":"10.1053\/j.seminhematol.2026.06.002_bib0071","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1182\/blood-2013-03-488874","article-title":"Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus\/newborn in a murine model","volume":"122","author":"Stowell","year":"2013","journal-title":"Blood."},{"issue":"12","key":"10.1053\/j.seminhematol.2026.06.002_bib0072","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/blood.2022018591","article-title":"Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression","volume":"142","author":"Jajosky","year":"2023","journal-title":"Blood."},{"issue":"5","key":"10.1053\/j.seminhematol.2026.06.002_bib0073","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/trf.16872","article-title":"Clodronate inhibits alloimmunization against distinct red blood cell alloantigens in mice","volume":"62","author":"Arthur","year":"2022","journal-title":"Transfusion (Paris)."},{"issue":"22","key":"10.1053\/j.seminhematol.2026.06.002_bib0074","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121631","article-title":"Complement serves as a switch between CD4+ T cell-independent and -dependent RBC antibody responses","volume":"3","author":"Mener","year":"2018","journal-title":"JCI Insight."},{"issue":"21","key":"10.1053\/j.seminhematol.2026.06.002_bib0075","first-page":"2642","article-title":"Prior immunization against an intracellular antigen enhances subsequent red blood cell alloimmunization in mice","volume":"141","author":"Jajosky","year":"2023","journal-title":"Blood."},{"issue":"6","key":"10.1053\/j.seminhematol.2026.06.002_bib0076","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1084\/jem.20151720","article-title":"Bridging channel dendritic cells induce immunity to transfused red blood cells","volume":"213","author":"Calabro","year":"2016","journal-title":"J Exp Med."},{"issue":"11","key":"10.1053\/j.seminhematol.2026.06.002_bib0077","doi-asserted-by":"crossref","first-page":"e440","DOI":"10.3324\/haematol.2016.149278","article-title":"Interleukin-6 receptor-alpha signaling drives anti-RBC alloantibody production and T-follicular helper cell differentiation in a murine model of red blood cell alloimmunization","volume":"101","author":"Arneja","year":"2016","journal-title":"Haematologica."},{"key":"10.1053\/j.seminhematol.2026.06.002_bib0078","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.629608","article-title":"Antibodies to Low-Copy Number RBC Alloantigen Convert a Tolerogenic Stimulus to an Immunogenic Stimulus in Mice","volume":"12","author":"Jash","year":"2021","journal-title":"Front Immunol."},{"key":"10.1053\/j.seminhematol.2026.06.002_bib0079","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3389\/fimmu.2018.02516","article-title":"Marginal Zone B Cells Induce Alloantibody Formation Following RBC Transfusion","volume":"9","author":"Patel","year":"2018","journal-title":"Front Immunol."},{"issue":"8","key":"10.1053\/j.seminhematol.2026.06.002_bib0080","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1182\/blood.2020009376","article-title":"Marginal zone B cells mediate a CD4 T-cell-dependent extrafollicular antibody response following RBC transfusion in mice","volume":"138","author":"Zerra","year":"2021","journal-title":"Blood."},{"key":"10.1053\/j.seminhematol.2026.06.002_bib0081","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3389\/fimmu.2018.02516","article-title":"Marginal Zone B Cells Induce Alloantibody Formation Following RBC Transfusion","volume":"9","author":"Patel","year":"2018","journal-title":"Front Immunol."},{"issue":"8","key":"10.1053\/j.seminhematol.2026.06.002_bib0082","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1182\/blood.2020009376","article-title":"Marginal zone B cells mediate a CD4 T-cell-dependent extrafollicular antibody response following RBC transfusion in mice","volume":"138","author":"Zerra","year":"2021","journal-title":"Blood."},{"issue":"8","key":"10.1053\/j.seminhematol.2026.06.002_bib0083","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167665","article-title":"Complement C3 and marginal zone B cells promote IgG-mediated enhancement of RBC alloimmunization in mice","volume":"134","author":"Jash","year":"2024","journal-title":"J Clin Invest."},{"issue":"1","key":"10.1053\/j.seminhematol.2026.06.002_bib0084","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1182\/asheducation-2016.1.452","article-title":"Cellular immune responses in red blood cell alloimmunization","volume":"2016","author":"Zimring","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.06.002_bib0085","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1016\/S2352-3026(23)00066-2","article-title":"Alloimmunisation against red blood cells in sickle cell disease: transfusion challenges in high-income and low-income countries","volume":"10","author":"Pirenne","year":"2023","journal-title":"Lancet Haematol."},{"issue":"3","key":"10.1053\/j.seminhematol.2026.06.002_bib0086","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2011-11-327361","article-title":"Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management","volume":"120","author":"Yazdanbakhsh","year":"2012","journal-title":"Blood."},{"issue":"6","key":"10.1053\/j.seminhematol.2026.06.002_bib0087","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","article-title":"High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors","volume":"122","author":"Chou","year":"2013","journal-title":"Blood."},{"issue":"8","key":"10.1053\/j.seminhematol.2026.06.002_bib0088","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1111\/trf.12639","article-title":"Immunosuppressants and alloimmunization against red blood cell transfusions","volume":"54","author":"Zalpuri","year":"2014","journal-title":"Transfusion (Paris)."},{"issue":"4","key":"10.1053\/j.seminhematol.2026.06.002_bib0089","article-title":"Complement involvement in sickle cell disease","volume":"52","author":"Meuleman","year":"2023","journal-title":"Presse Medicale Paris Fr 1983."},{"issue":"11","key":"10.1053\/j.seminhematol.2026.06.002_bib0090","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1172\/JCI64578","article-title":"Extracellular hemin crisis triggers acute chest syndrome in sickle mice","volume":"123","author":"Ghosh","year":"2013","journal-title":"J Clin Invest."},{"issue":"4","key":"10.1053\/j.seminhematol.2026.06.002_bib0091","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/jha2.779","article-title":"The role of tocilizumab in the treatment of post-transfusion hyperhaemolysis","volume":"4","author":"Desai","year":"2023","journal-title":"EJHaem."},{"issue":"8","key":"10.1053\/j.seminhematol.2026.06.002_bib0092","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2015-09-669770","article-title":"Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients","volume":"127","author":"Dumas","year":"2016","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2026.06.002_bib0093","doi-asserted-by":"crossref","first-page":"e483","DOI":"10.3324\/haematol.2018.194670","article-title":"Contribution of alternative complement pathway to delayed hemolytic transfusion reaction in sickle cell disease","volume":"103","author":"Chonat","year":"2018","journal-title":"Haematologica."},{"issue":"12","key":"10.1053\/j.seminhematol.2026.06.002_bib0094","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.3324\/haematol.2020.262006","article-title":"Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease","volume":"105","author":"Chonat","year":"2020","journal-title":"Haematologica."},{"issue":"807","key":"10.1053\/j.seminhematol.2026.06.002_bib0095","doi-asserted-by":"crossref","first-page":"eadl4922","DOI":"10.1126\/scitranslmed.adl4922","article-title":"Complement is activated in patients with acute chest syndrome caused by sickle cell disease and represents a therapeutic target","volume":"17","author":"Chonat","year":"2025","journal-title":"Sci Transl Med."},{"key":"10.1053\/j.seminhematol.2026.06.002_bib0096","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.901876","article-title":"Heme Interferes With Complement Factor I-Dependent Regulation by Enhancing Alternative Pathway Activation","volume":"13","author":"Gerogianni","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.06.002_bib0097","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/imm.13708","article-title":"Insights into the molecular basis and mechanism of heme-triggered TLR4 signalling: The role of heme-binding motifs in TLR4 and MD2","volume":"171","author":"Hopp","year":"2024","journal-title":"Immunology"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196326000600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196326000600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:27:02Z","timestamp":1785209222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196326000600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":97,"alternative-id":["S0037196326000600"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2026.06.002","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alloimmunization in sickle cell disease: Addressing an ongoing clinical challenge","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2026.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}